Search Within

Gopakumar Vasudeva Iyer

Formats
  1. Meeting Abstract (205)
  2. Journal Article (124)
  3. Review (11)
  4. Book Section (5)
  5. Editorial (3)
  6. Correspondence (2)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (352)
  2. Genitourinary Oncology Service (352)
  3. Solid Tumor Oncology Division (352)
  4. Department of Pathology and Laboratory Medicine (217)
  5. GSK Faculty (196)
  6. Human Oncology and Pathogenesis Program (193)

More Groups

People
  1. Hikmat Al-Ahmadie (184)
  2. David Solit (183)
  3. Jonathan Rosenberg (175)
  4. Dean Bajorin (163)
  5. Bernard Bochner (130)
  6. Michael Berger (102)

More People

Years
  1. 2025 (24)
  2. 2024 (41)
  3. 2023 (30)
  4. 2022 (33)
  5. 2021 (34)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (120)
  2. Laboratory Investigation (27)
  3. Modern Pathology (21)
  4. Cancer Research (17)
  5. Annals of Oncology (14)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (130)
  2. Nature Publishing Group (43)
  3. American Association for Cancer Research (34)
  4. Elsevier Inc. (33)
  5. Nature Research (21)
  6. Oxford University Press (16)

More Publishers

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical, molecular and immunohistochemical profiles of nested subtype of urothelial carcinoma
    Meeting Abstract

    Basar Yerebakan, M.; Clinton, T.; Whiting, K.; Chu, C.; Ozcan, G. G.; Akbulut, D.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Genomic landscape of urothelial carcinoma with divergent differentiation and histologic subtypes
    Meeting Abstract

    Chu, C.; Chen, Z.; Whiting, K.; Rammal, R.; Lenis, A.; Ozcan, G. G.; Akbulut, D.; Basar Yerebakan, M.; Chen, J. F.; Sirintrapun, S. J.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Pathological, clinical and molecular characterization of large cell neuroendocrine carcinoma (LCNEC) of the urinary tract
    Meeting Abstract

    Gandhi, J.; Guercio, B.; Mirsadraei, L.; Zhou, Q.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; Fine, S.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • The prognostic significance of stem cell-like marker PLCG2 and novel neuroendocrine markers in bladder neuroendocrine carcinomas
    Meeting Abstract

    Akbulut, D.; Ozcan, G. G.; Basar Yerebakan, M.; Whiting, K.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Sirintrapun, J.; Fine, S.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1
    Review

    Hensley, P. J.; Seiler, R.; Herr, H.; Mouw, K. W.; Iyer, G.; Dyrskjøt, L.; Nawroth, R.; Goebell, P.; Schmitz-Drager, B.; Todenhofer, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer
    Journal Article

    Qiu, H.; Makarov, V.; Bolzenius, J. K.; Halstead, A.; Parker, Y.; Wang, A.; Iyer, G. V.; Wise, H.; Kim, D.; Thayaparan, V.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Phase 2 clinical study evaluating the efficacy and safety of disitamab vedotin with or without pembrolizumab in patients with HER2-expressing urothelial carcinoma (RC48G001)
    Meeting Abstract

    Powles, T.; Yu, E. Y.; Iyer, G.; Campbell, M. T.; Loriot, Y.; De Santis, M.; O'Donnell, P. H.; Burgess, E. F.; Necchi, A.; Krieger, L. E. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2, multicenter, open-label basket trial of nab-sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I)
    Meeting Abstract

    Iyer, G.; Demeure, M. J.; Deming, D. A.; Federman, N.; McKean, M.; Lee, E. K.; Spira, A. I.; Kwiatkowski, D. J.; Hussein, M. A.; Gordon, E. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Katims, A. B.; Lenis, A. T.; Shah, R. H.; Chu, C. E.; Ratna, N.; Regazzi, A. M.; Pietzak, E. J.; Aggen, D. H.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save